...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Private placement one million plus units for US$2, half wt exercisable at US3, good for 3 years

I think Dutch screwed up and saw the pp from last August.As you are correct.I private messaged Dutch for the info no reply

Share
New Message
Please login to post a reply